Hantech Bio-Technology Co (1294.TWO) Stock Price

Hantech Bio-Technology Co Price

CLOSED
48.25
​
Market closed

Revenue has compounded at 37.4% per year over the past 6 years to 778.54 M TWD. Earnings per share have grown at 53.7% per year over the last 6 years. Hantech Bio-Technology Co's net margin stands at 17.9%, up from 13.5% several years earlier. Hantech Bio-Technology Co currently offers a dividend yield of about 4.91%. The payout ratio is around 62% of earnings. The dividend has grown at 101.7% per year over the past 2 years.

Hantech Bio-Technology Co stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Hantech Bio-Technology Co business model & stock analysis

Hantech Bio-Technology Co., Ltd. generates revenue by manufacturing and selling science-based health products, eco-friendly pouches, and dietary supplements. The company provides functional drinks, including health drinks and crystal jelly, and powder raw materials and capsules such as pearl powder and tortoise-deer concentrated powder. Products are sold to markets in China, Southeast Asia, and America, with packaging options ranging from square bags to wine bottle bags in capacities of 10-80ml (g). The firm focuses on functional drink production, offering health drinks and crystal jelly in various shaped pouches like round mouth bottles, Z-shaped bags, and stand-up bags. Powder raw materials and capsule products include pearl powder and tortoise-deer concentrated powder, targeting consumers seeking health and wellness solutions. Sales are distributed across China, Southeast Asia, and American regions. Hantech Bio-Technology Co., Ltd. serves customers in China, Southeast Asia, and America through its eco-friendly packaging solutions and science-based health products. The company’s product portfolio includes functional drinks, crystal jelly, and dietary supplements with diverse packaging formats. Sales are driven by the demand for health-focused products in these key markets.

Frequently asked questions about Hantech Bio-Technology Co

7 analysts currently rate the Hantech Bio-Technology Co stock: 0 recommend buying, 3 holding and 4 selling.

Converted at the current exchange rate, the Hantech Bio-Technology Co share trades at 1.31 EUR (48.25 TWD).

The revenue cannot currently be calculated for Hantech Bio-Technology Co.

The profit cannot currently be calculated for Hantech Bio-Technology Co.

The P/E ratio cannot be calculated for Hantech Bio-Technology Co at the moment.

The P/S cannot be calculated for Hantech Bio-Technology Co currently.

The Eulerpool Quality Score for Hantech Bio-Technology Co is 7/10.

The ISIN of Hantech Bio-Technology Co is TW0001294007. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Hantech Bio-Technology Co is 1294.TWO. The ticker symbol is used to trade Hantech Bio-Technology Co shares on the stock exchange.

Fair ValueTerminal
41.01 TWD
Over-/UndervaluationTerminal
Fairly valued
Industry
Personal Care Products
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website htbios.com
Country
Taiwan
Currency
TWD
Initial public offering
Sep 30, 2022
ISIN
TW0001294007
Cusip
Y3R6CC113
Market capitalization
1.48 B TWDSmall Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
—
P/S
P/Se
—
EV/EBIT
7.46
P/B Ratio
1.78
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
15.48 %
Dividend
Dividend yield
4.91 %
Est. Dividend Yield
5.89 %
Payout Ratio
61.90 %
Dividend growth Ø5Y
—
Dividend payments per year
1
Dividend paid since
3 years
Dividend not reduced since
3 years
Dividend increased since
1 year
Dividend withholding tax
21.00 %
Last updated Nov 5, 2026, 3:37 AM

Hantech Bio-Technology Co Peer Group

Hantech Bio-Technology Co FIGI

1294:TT (Taipei Stock Exchange) · BBG019RSB9G9

All fundamentals and in-depth analysis of Hantech Bio-Technology Co

Our stock analysis for Hantech Bio-Technology Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Hantech Bio-Technology Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.